Literature DB >> 19340004

Functional characterization of an activating TEK mutation in acute myeloid leukemia: a cellular context-dependent activating mutation.

J W Tyner, M L Rutenberg-Schoenberg, H Erickson, S G Willis, T O'Hare, M W Deininger, B J Druker, M M Loriaux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19340004     DOI： 10.1038/leu.2009.66

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  4 in total

1.  ROBO1 deletion as a novel germline alteration in breast and colorectal cancer patients.

Authors:  Rolando A R Villacis; Francine B Abreu; Priscila M Miranda; Maria A C Domingues; Dirce M Carraro; Erika M M Santos; Victor P Andrade; Benedito M Rossi; Maria I Achatz; Silvia R Rogatto
Journal:  Tumour Biol       Date:  2015-10-01

2.  The BCR-ABL35INS insertion/truncation mutant is kinase-inactive and does not contribute to tyrosine kinase inhibitor resistance in chronic myeloid leukemia.

Authors:  Thomas O'Hare; Matthew S Zabriskie; Christopher A Eide; Anupriya Agarwal; Lauren T Adrian; Huihong You; Amie S Corbin; Fei Yang; Richard D Press; Victor M Rivera; Julie Toplin; Stephane Wong; Michael W Deininger; Brian J Druker
Journal:  Blood       Date:  2011-09-08       Impact factor: 22.113

3.  Computational and Experimental Characterization of Patient Derived Mutations Reveal an Unusual Mode of Regulatory Spine Assembly and Drug Sensitivity in EGFR Kinase.

Authors:  Zheng Ruan; Samiksha Katiyar; Natarajan Kannan
Journal:  Biochemistry       Date:  2016-12-22       Impact factor: 3.162

4.  Novel Method Enabling the Use of Cryopreserved Primary Acute Myeloid Leukemia Cells in Functional Drug Screens.

Authors:  Michelle Degnin; Anupriya Agarwal; Katherine Tarlock; Soheil Meshinchi; Brian J Druker; Cristina E Tognon
Journal:  J Pediatr Hematol Oncol       Date:  2017-10       Impact factor: 1.289
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.